How Computation Predictions Empower Drug Discovery
Michelle Arkin, PhD, of the University of California, San Francisco, discusses the growing applications of AI and ML with contributing editor Tanuja Koppal, PhD
Drug Discovery
How ELNs Can Help to Drive Innovation in Life Sciences
Electronic lab notebooks have the potential to significantly improve data management issues in biopharmaceutical development
Insights into the Main Stages of Pharmaceutical Discovery and Development
Key challenges and solutions at each stage of drug development
3Brain AG CorePlate™ Technology Combines Microchips and AI In a Revolutionary New Approach to Drug Discovery
New tech promises to change the way drug candidates are selected at the preclinical level to enter into clinical trials—and to maximize their chances of success
Repurposed Drugs Present New Strategy for Treating COVID-19
Virtual screening of 6,218 drugs and cell-based assays identifies best therapeutic medication candidates
Certara Releases New Versions of Its Preeminent Quantitative Systems Pharmacology (QSP) Simulators for Expediting Development of Biologics and Immuno-Oncology Therapies
Expanded capabilities in company’s Immunogenicity and Immuno-oncology QSP Simulators broaden applicability for addressing safety and efficacy challenges
Accelerate Drug Discovery and Development
Industry-approved fluidic-free standard for label-free molecular interaction analysis
Accelerating Flow Cytometry's Potential for Drug Screening
New applications also provide a boost for the technique's possible use in subcellular characterization
A Novel Technique to Automate Pharmaceutical Compound Production
Demonstrating the novel technique on prexersatib, research team achieves a fully automated six-step synthesis with 65 percent isolated yield within 32 hours
Digitally Integrating Automated Stores and Manual Processes
Understanding your digital integration requirements